Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury

KA Fernandes, KL Mitchell, A Patel, OJ Marola… - Experimental eye …, 2018 - Elsevier
Optic neuropathies such as glaucoma are characterized by the degeneration of retinal
ganglion cells (RGCs) and the irreversible loss of vision. In these diseases, focal axon injury …

[HTML][HTML] Vascular derived endothelin receptor A controls endothelin-induced retinal ganglion cell death

OJ Marola, GR Howell, RT Libby - Cell Death Discovery, 2022 - nature.com
Endothelin (EDN, also known as ET) signaling has been suggested to be an important
mediator of retinal ganglion cell (RGC) death in glaucoma. Antagonism of EDN receptors (…

[HTML][HTML] BAX activation in mouse retinal ganglion cells occurs in two temporally and mechanistically distinct steps

ME Maes, RJ Donahue, CL Schlamp, OJ Marola… - Molecular …, 2023 - Springer
Background Pro-apoptotic BAX is a central mediator of retinal ganglion cell (RGC) death after
optic nerve damage. BAX activation occurs in two stages including translocation of latent …

[HTML][HTML] Endothelin 1-induced retinal ganglion cell death is largely mediated by JUN activation

OJ Marola, SB Syc-Mazurek, GR Howell… - Cell death & disease, 2020 - nature.com
Glaucoma is a neurodegenerative disease characterized by loss of retinal ganglion cells (RGCs),
the output neurons of the retina. Multiple lines of evidence show the endothelin (EDN, …

[HTML][HTML] DDIT3 (CHOP) contributes to retinal ganglion cell somal loss but not axonal degeneration in DBA/2J mice

OJ Marola, SB Syc-Mazurek, RT Libby - Cell death discovery, 2019 - nature.com
Glaucoma is an age-related neurodegenerative disease characterized by the progressive
loss of retinal ganglion cells (RGCs). Chronic ocular hypertension, an important risk factor for …

[HTML][HTML] Transcriptional control of retinal ganglion cell death after axonal injury

SB Syc-Mazurek, HS Yang, OJ Marola… - Cell Death & …, 2022 - nature.com
Injury to the axons of retinal ganglion cells (RGCs) is a key pathological event in
glaucomatous neurodegeneration. The transcription factors JUN (the target of the c-Jun N-terminal …

New directions for Alzheimer's disease research from the Jackson Laboratory Center for Alzheimer's and Dementia Research 2022 workshop

…, TJ Murdy, OJ Marola… - … Research & Clinical …, 2024 - Wiley Online Library
INTRODUCTION In September 2022, The Jackson Laboratory Center for Alzheimer's and
Dementia Research (JAX CADR) hosted a workshop with leading researchers in the …

[HTML][HTML] BclXL (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury

OJ Marola, SER Yablonski, PG Shrager… - Cell Death …, 2022 - nature.com
Glaucoma, a leading cause of irreversible blindness, is characterized by loss of retinal ganglion
cells (RGCs). In glaucoma, RGCs are thought to sustain axonal injury at the glial lamina […

Gabor domain optical coherence microscopy combined with laser scanning confocal fluorescence microscopy

…, Y Qi, H Mestre, C Canavesi, OJ Marola… - Biomedical Optics …, 2019 - opg.optica.org
We report on the development of fluorescence Gabor domain optical coherence microscopy
(Fluo GD-OCM), a combination of GD-OCM with laser scanning confocal fluorescence …

Genetic context modulates aging and degeneration in the murine retina

M MacLean, OJ Marola, CA Diemler, TL Cossette… - bioRxiv, 2024 - biorxiv.org
Background: Age is the principal risk factor for neurodegeneration in both the retina and brain.
The retina and brain share many biological properties; thus, insights into retinal aging and …